Progress 09/01/21 to 02/29/24
Outputs Target Audience:The target audience included other scientists especially parasitologists and food safety scientists at the USDA, CDC and elsewhere. Presentations were made to the Cyclospora Task Force headed by Dr. Alex daSilva of the USDA on May 28, 2024 and the key results were published here:Bruno J.G., Sivils J. Natarajan M. DNA Aptamer-Based Staining and Fluorescence Microscopy for Rapid Detection of Cyclospora cayetanensis Oocysts. J. Fluorescence. 2023 Dec 18. doi: 10.1007/s10895-023-03533-4. PMID: 38109032.In addition, personnel from Ancera Inc., Eurofins, the Center for Produce Safety and Taylor Farms have been briefed on the results of this Phase II project with the hope of striking a business deal of some sort via Nanohmics' business consultant James Byron of Xgenex. Changes/Problems:The only major change was abandoning of the lateral flow format in favor of more sensitive aptamer-quantum dot fluorescence staining of Cyclospora cyatanensis oocysts on filters and detecting them within minutes using Nanohmics prototype field-portable microscope. Nanohmics' prototypemicroscope resembled the one developed in the following publication: Oyibo P., et al.Schistoscope: An Automated Microscope with Artificial Intelligence for Detection of Schistosoma haematobium Eggs in Resource-Limited Settings. Micromachines 2022, 13, 643. https:// doi.org/10.3390/mi13050643. What opportunities for training and professional development has the project provided?Several lab technicians at Nanohmics and the Univ. of Texas Health Sciences Center in San Antonio (UTHSCSA) were trained in aspects of SELEX aptamer development, immunofluorescence staining, confocal fluorescence microscopy and image analysis including pattern recognition algorithms for Cyclospora oocyst discrimination at Nanohmcis. How have the results been disseminated to communities of interest?Results were disseminated via the 2023 J. Fluorescence peer-reviewed publication as well as Dr. Bruno's presentation to the Cyclospora Task Force and James Byron's briefings to interested industry representatives at the Center for Produce Safety, Eurofins, Ancera, Taylor Farms, etc. What do you plan to do during the next reporting period to accomplish the goals?While the project has officially ended, Nanohmics and James Byron continue to engage interested agricultural industry parties.
Impacts What was accomplished under these goals?
The top aptamer DNA sequences were narrow to 4 sequences against the TA4-likeantigen, Wall Protein (WP)-2 and whole cell/oocysts (WC) by ELISA-like titration assays reported in the J. Fluorescence 2023 paper. These were then used in extensive cross-reactivity studies by confocal fluorescence microscopy reported in the 72 page supplemental file published with the J. Fluorescence article to prove aptamer specificity. A prototype field-portable microscope to find and detect Cyclsopora on 5 um pore size filters within minutes after aptamer-fluorophore (quantum dot) staining, washing and image analysis was also built and tested. Nanohmics proved that while lateral flow aptamer-quantum dot test strips were feasible, they could never be as sensitive as the field microscope with its theoretical limit of detection of one Cyclospora oocyst. The project led to briefings of the new technology to Ancera, Eurofins, Taylor Farms, the USDA's Cyclospora Task Force including Drs. Alex daSilva, Ben Rosenthal and Mark Jenkins.
Publications
- Type:
Journal Articles
Status:
Published
Year Published:
2023
Citation:
2. Bruno J.G., Sivils J. Natarajan M. DNA Aptamer-Based Staining and Fluorescence Microscopy for Rapid Detection of Cyclospora cayetanensis Oocysts. J. Fluorescence. 2023 Dec 18. doi: 10.1007/s10895-023-03533-4. PMID: 38109032
|
Progress 09/01/22 to 08/31/23
Outputs Target Audience:The target audience includes scientists working in environmental protection, food safety, and all food producers especially in the fresh produce industry. Changes/Problems:
Nothing Reported
What opportunities for training and professional development has the project provided?In addition to training of one optical scientist and two engineers in 3D CAD design and construction of the new semi-automated fluorescence microscope including 3D printed parts, even the PI (Dr. Bruno) has been learning new levels ofparasitology by aquiring and testing a variety of non-Cyclospora waterborne parasites from commercial sources, the CDC, FDA and USDA for cross-reactivity of the top aptamer DNA sequences. How have the results been disseminated to communities of interest?Yes,Nanohmics is using publications, trade shows and word of mouth to communicate the progress on this Phase II project to the broader community. Eventually, its website and Xgenex's website will probably be used to disseminate the information further. What do you plan to do during the next reporting period to accomplish the goals?Finalize publication of the aptamer staining results in the Journal of Fluorescence, sign the commercial consulting deal with Mr. Byron at Xgenex and begin promotion of the technology to the business and scientific communities.
Impacts What was accomplished under these goals?
Essntially, TOs 1-4 are completed at this point, but a no cost extension was granted through29 Feb 2024 to enable full completion of TO4 and to allow enactment of aconsulting and businessagreement with Xgenex Inc. to promote the combined aptamer-fluorophore staining and filter-based semi-automated fluorescence microscopicdetection of as few as one Cyclospora cayetanensis oocysttechnology to large companies for partnership, licensing or acquisition.
Publications
- Type:
Journal Articles
Status:
Submitted
Year Published:
2023
Citation:
Bruno J.G., Sivils J. Natarajan M. DNA Aptamer-Based Staining and Fluorescence Microscopy for Rapid Detection of Cyclospora cayetanensis Oocysts. J. Fluorescence. Submitted 2023.
|
Progress 09/01/21 to 08/31/22
Outputs Target Audience:The target audience includes scientists working in environmental protection, food safety, and all food producers especially in the fresh produce industry. Changes/Problems:
Nothing Reported
What opportunities for training and professional development has the project provided?In addition to training of one optical scientist and two engineers in 3D CAD design and construction of the new semi-automated fluorescence microscopeincluding 3D printed parts, even the PI (Dr. Bruno) has been learning new levels of parasitology by aquiring and testing a variety of non-Cyclospora parasites for cross-reactivity testing from other companies, the CDC and USDA sources. How have the results been disseminated to communities of interest?Nanohmics is using publications and word of mouth to communicate the progress on this Phase II project to the broader community. Eventually, its website and Xgenex's website will probably be used to disseminae the information further. What do you plan to do during the next reporting period to accomplish the goals?1. Complete cross-reactivity testing of the top 8 Phase I aptamers and top 2 whole oocyst aptamers form Phase iI versus Cyclospora cayetanensis, Cryptosporidium, Emeriae, Amoeba, Giardia and other parasites by confocal fluorescence microscopy and enzyme-linked aptamer assays. 2. Complete and test the semi-automated autofocus filter-based epifluorescence microscope prototype and test it with red, green and blue 8 um fluorescent beads from Bangs Laboratories as well as real Cyclospora oocysts and other parasites. 3. Publish the results of 1 and 2 above. 4. Begin marketing or licensing of the system via information from LARTA or via Xgenex.com. 5. Write and submit the Phase II final report.
Impacts What was accomplished under these goals?
TO-1: The top 8 aptamer DNA sequences developed against the recombinant TA4-like antigen and Wall Protein 2 of Cyclospora cayetanensis from Phase I were tested for surface binding on C. cayetanensis oocysts obtained from Dr. Michael Arrowood at the CDC by Prof. Mohan Natarajan at the University of Texas Health Science Center in San Antonio and all 8 aptamers exhibited strong oocyst surface binding by confocal fluorescence microscopy as reported in: Bruno J.G. Applications in Which Aptamers Are Needed or Wanted in Diagnostics and Therapeutics. Pharmaceuticals (MDPI; Open Access). 15(6), 693, 2022; https://doi.org/10.3390/ph15060693. New aptamers against whole Cyclospora cayetanensis oocysts were developed during year 1 of Phase II and resulted in numerous new aptamer DNA sequences as listed in Table 1 below. The top two sequences from Table 1 (S3 and S16) are currently being tested by both confocal fluorescence microscopy against Cyclospora, Acanthamoeba, Cryptosporidium, Eimaria spp, Encephalitazoon, Giardia, Nagleria fowleri, etc. obatined from the Native Antigen Co. in the U.K. as well as Waterborne Inc., the CDC and USDA (Dr. Mark Jenkins). Results will be reported in year 2. All aptamer DNA sequences were obtained via Illumina sequencing at Base Pair Inc. Table 1 - Top Aptamer DNA sequences against whole Cyclospora cayetanensis oocysts having > 2 ppm frequency in the final aptamer pool Tag Seq Seq Cluster Seq Cluster Prcnt Seq Cluster Pos fcount ppm S16 CCTGGGAGAAGGGAGCGGATCAGCTACACCCTATAG 1 * 1 727 236.46 S3 ACGCTCACCAGTTGCTATATGAAATTGCCTATGGCC 2 * 1 223 72.53 S157 TAAAGTAGAGGCTGTTCTCCAGACGTCGCAGGAGGA x * 1 45 14.64 S200 CCTGGGAGAAGGGAGCGGATCAGCTACACTCTATAG 1 97.22 2 29 9.43 S446 CCTGGGAGAAGGGAGCGGATCAGCTACACCCTACAG 1 97.22 3 27 8.78 S15 CCTGGGAGAAGGGAGCGGATCAGCTACACCCTGTAG 1 97.22 4 16 5.20 S3689 CCCACTTCGTAACAGCAACGAACCTAGATAAGTGCT x * 1 14 4.55 S68 TCTGGGAGAAGGGAGCGGATCAGCTACACCCTATAG 1 97.22 5 13 4.23 S5490 GTCAAAACGTAAGGCATCATTGTCATCGACGTTCCA x * 1 13 4.23 S6452 GGAGATACCACAGGGGGAACATGCCATTGTGCTCTA x * 1 11 3.58 S670 CCTGGGAGAAGGGAGCGGATCAGCTACGCCCTATAG 1 97.22 6 10 3.25 S292 ACCTCACTCTGTGTAGGTCCTGTTATAGAGGTAACG x * 1 10 3.25 S1232 CCCGGGAGAAGGGAGCGGATCAGCTACACCCTATAG 1 97.22 7 9 2.93 S4985 GGTCTCGATGCTACTAATACATAAACAGGAGTGGTA x * 1 9 2.93 S5967 GCAACTGATTGTGTCAATATGGCTTCTACACCGTCC x * 1 9 2.93 S1005 CCTGGGAGAAGGGAGCGGACCAGCTACACCCTATAG 1 97.22 8 8 2.60 S1167 CCTGGGGGAAGGGAGCGGATCAGCTACACCCTATAG 1 97.22 9 8 2.60 S1621 CCGCTCACCAGTTGCTATATGAAATTGCCTATGGCC 2 97.22 2 8 2.60 S945 CCCCCGCAACCTAACGTGGCAGCCATATTATATCAC x * 1 8 2.60 S6722 GCTTCTTCGTTTAACTACTAGACACTCGGACTGTAC x * 1 8 2.60 S182 CGTGGGAGAAGGGAGCGGATCAGCTACACCCTATAG 1 97.22 10 7 2.28 S340 CCTGGGAGGAGGGAGCGGATCAGCTACACCCTATAG 1 97.22 11 7 2.28 S1818 CCTGGGAGAAGGGAACGGATCAGCTACACCCTATAG 1 97.22 12 7 2.28 S2843 GCATTGGTGACCCTCGCGTGGACTACCCAAAGCAGG x * 1 7 2.28 S3923 GCACGGTTTCACTTGAAAAGACGCGGCACAATTCGT x * 1 7 2.28 S5503 ACAATCATTGCAGCGCATTCAGGCATGAACTTACAG x * 1 7 2.28 S6830 CGAGAAGGTTGAAAATCCAAAGAGATCCCTACTGGA x * 1 7 2.28 S6865 GCGATGTAATGTACCCTGCTGATTGGTTCCTACTAG x * 1 7 2.28 TO-2: Nanohmics made a decision to exclusively pursue the semi-automated fluorescence microscope route in Phase II, because despite the extreme sensitivity of quantum dot-based lateral flow test strips, its engineers have been able to show detection of one oocyst or 8 um fluorescent bead surrogate in a matter of one hour or less on a 47 mm diameter filter using microscopy which is a level of sensitivity that quantum dot-lateral flow test strips cannot match. TO-3: Nanohmics continues to work on this TO, by adapting its 47 mm filtration system to the much larger water pre-filtration system for Cyclospora already used by the FDA and described inBAM 19c: Dead-end Ultrafiltration for the Detection of Cyclospora cayetanensis from Agricultural Water. TO-4: Nanohmics now has a working bench top protoype semi-automated epi-fluorescence microscope that it can probably produce for < $1,000 per unitwhich will accomodate and rapidly scan 47 mm diameter low fluorescence carbonate disk filters on which to capture Cyclospora and other parasites from agricultural water concentrates or diluted sewage and fresh produce rinsates. Nanohmics'design resembles the microscope design in the following publication: Oyibo P., et al. Schistoscope: An AutomatedMicroscope with ArtificialIntelligence for Detection ofSchistosoma haematobium Eggs in Resource-Limited Settings.Micromachines 2022, 13, 643. https://doi.org/10.3390/mi13050643 TO-5: Nanohmics continues working with Dr. Calcaterra at LARTA as well as Mr. James Byron at Xgenex to develop the appropriate food safety and food production industry contacts to market the semi-automated microscope and anti-Cyclospora aptamers for staining of the parasites on filters. TO-6: This report satisfies the annual report requirement.
Publications
- Type:
Journal Articles
Status:
Published
Year Published:
2022
Citation:
Bruno J.G. Applications in Which Aptamers Are Needed or Wanted in Diagnostics and Therapeutics. Pharmaceuticals (MDPI; Open Access). 15(6), 693; 2022. https://doi.org/10.3390/ph15060693. Note: Publication includes aptamer-fluorophore staining and confocal fluorescence microscopy of Cyclospora oocysts.
|
|